- Corporate
- The share
- Press releases
- Financial calendar
- Financial reports
- Financial reports – ESEF
- Prospectus and material offerings
- Financial presentations
- Corporate governance
- Analyst Coverage
- Code of Conduct
- Environmental Policy
- Code of Conduct for Suppliers
- Privacy policy
- Contact us
- Subscribe
- Thank you
- Error
Conference call on Interim Report
Time: Friday, July 10, 2020 at 2.00 p.m. CET
Information regarding the conference can be found under the following link:
https://onlinexperiences.com/Launch/QReg/ShowUUID=4942D3FE-A7DD-4260-92DB-B2391D5B83D2
Phone numbers to the conference:
Sweden dial in number: +46 856 642 651
USA dial in number: +1 631 913 1422
International (UK) dial in number: +44 (0)3333 000 804
Conference name: XVIVO Perfusion, Conference ID: 84626045#
Participants from XVIVO Perfusion:
Dag Andersson, CEO
Christoffer Rosenblad, CFO
The press release for XVIVO Perfusion’s interim report April-June 2020 will be released on July 10, 2020 at 7:30 a.m. CET.
Before the conference call, slides will be available at the company web page, www.xvivoperfusion.com/corporate/.
July 2, 2020
Gothenburg
XVIVO Perfusion AB (publ)
For further information please contact:
Christoffer Rosenblad, CFO, +46 735 192159, christoffer.rosenblad@xvivoperfusion.com
Dag Andersson, CEO, +46 31-788 21 50, e-post: dag.andersson@xvivoperfusion
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.
